The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Survival differences among women with de novo stage IV and relapsed breast cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500 · cited 1×
“Trastuzumab has been shown in randomized clinical trials to have significantly improved the survival of women with HER2-positive metastatic disease [16] and recent data also indicate that the introduction of trastuzumab into standard therapy may have changed the natural history of HER2-positive breast tumors such that…”
BackgroundSørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Cancer: Principles and Practice of Oncology
Gunn, W. G. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510350091047 · Cited by 1,791
Lamon, D. E. J. S., Eyland, B. R. L., Hak, S. T. S., Uchs, H. A. F., Aton, V. I. P., Ajamonde, A. L. B., LeMing, T., Iermann, W. O. E., Olter, J. A. W., Egram, M. A. P., et al. (2009) · Cited by 1,199
Sapisochin, E. (1962) · PubMed · Cited by 908
Dawood, S., Broglio, K., Buzdar, A. U., Hortobagyi, G. N., & Giordano, S. H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9844 · Cited by 758
Self-citationGiordano, S. H., Buzdar, A. U., Smith, T. L., Kau, S., Yang, Y., & Hortobagyi, G. N. (2004) · Cancer · doi:10.1002/cncr.11859 · Cited by 540
Self-citationEffect of surgical removal on the growth and kinetics of residual tumor.
Gündüz, N., Fisher, B., & Saffer, E. (1979) · PubMed · Cited by 410
Breast Cancer With Synchronous Metastases: Trends in Survival During a 14-Year Period
Andre, F., Slimane, K., Bachelot, T., Dunant, A., Namer, M., Barrelier, A., Kabbaj, O., Spano, J. P., Marsiglia, H., Rouzier, R., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.095 · Cited by 394
Prognostic factors in 1038 women with metastatic breast cancer
Largillier, R., Ferrero, J.-M., Doyen, J., Barriere, J., Namer, M., Mari, V., Courdi, A., Hannoun-Levi, J. M., Ettore, F., Birtwisle-Peyrottes, I., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn424 · Cited by 373
Presence of a growth-stimulating factor in serum following primary tumor removal in mice.
Fisher, B., Gündüz, N., Coyle, J., Rudock, C., & Saffer, E. (1989) · PubMed · Cited by 361
Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual
Singletary, S. E., Allred, C., Ashley, P., Bassett, L. W., Berry, D., Bland, K. I., Borgen, P. I., Clark, G. M., Edge, S. B., Hayes, D. F., et al. (2003) · Surgical Clinics of North America · doi:10.1016/s0039-6109(03)00034-3 · Cited by 294
Third consensus on medical treatment of metastatic breast cancer
Beslija, S., Bonneterre, J., Burstein, H. J., Cocquyt, V., Gnant, M., Heinemann, V., Jassem, J., Köstler, W. J., Krainer, M., Menard, S., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp261 · Cited by 263
Association of Surgery With Improved Survival in Stage IV Breast Cancer Patients
Blanchard, D. K., Shetty, P. B., Hilsenbeck, S. G., & Elledge, R. M. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e3181656d32 · Cited by 254
Dawood, S., Broglio, K., Gonzalez-Angulo, A. M., Buzdar, A. U., Hortobagyi, G. N., & Giordano, S. H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1168 · Cited by 187
Self-citationCardoso, F., Leo, A. D., Lohrisch, C. A., Bernard, C., Ferreira, F., & Piccart, M. J. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf101 · Cited by 146
THE ROLE OF CHEMOTHERAPY FOR METASTATIC BREAST CANCER
Miller, K. D., & Sledge, G. W. (1999) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70063-0 · Cited by 58
Cited by
Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States
Mariotto, A. B., Etzioni, R., Hurlbert, M., Penberthy, L., & Mayer, M. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0889 · Cited by 529
Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer
Mehta, R. S., Barlow, W. E., Albain, K. S., Vandenberg, T. A., Dakhil, S. R., Tirumali, N. R., Lew, D. L., Hayes, D. F., Gralow, J. R., Livingston, R. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201622 · Cited by 371
Self-citationCaswell-Jin, J. L., Plevritis, S. K., Tian, L., Cadham, C. J., Xu, C., Stout, N. K., Sledge, G. W., Mandelblatt, J. S., & Kurian, A. W. (2018) · JNCI Cancer Spectrum · doi:10.1093/jncics/pky062 · Cited by 315
Clinical implications of cancer self-seeding
Comen, E., Norton, L., & Massagué, J. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.64 · Cited by 312
Metadata
- Authors
- Dawood, S., Broglio, K., Ensor, J., Hortobagyi, G. N., & Giordano, S. H.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2010-11
- Volume
- 21
- Issue
- 11
- Pages
- 2169-2174
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2150027768
- Cited by
- 273
- References
- 19
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.